Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5615826 | The Journal of Heart and Lung Transplantation | 2017 | 26 Pages |
Abstract
Erythrocyte lifespan is substantially reduced in subjects with a CF-LVAD, which was more pronounced in the presence of device thrombosis. The etiology of anemia in CF-LVAD was primarily due to accelerated erythrocyte aging. Further studies are needed to determine whether erythrocyte lifespan could provide a practical means of detecting subtle pre-clinical thrombosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ziad MD, Ryan J. MD, Julie BS, Ashish PhD, Peter M. MD, Michael D. MD, Marc R. MD,